LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 19.69 | 84.90 | 423 | 1239 | 0.3413 | 0.5147 | MN20160318_Q02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 19.69 | 84.90 | 919 | 1239 | 0.7415 | 0.8512 | MN20160318_Q02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 19.69 | 84.90 | 1 | 1239 | 0.0008 | -0.6828 | MN20160318_Q02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 19.69 | 84.90 | 849 | 1239 | 0.6850 | 0.8136 | MN20160318_Q02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 21.40 | 84.90 | 518 | 1454 | 0.3561 | 0.5546 | MN20160318_Q02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 21.40 | 84.90 | 739 | 1454 | 0.5080 | 0.6954 | MN20160318_Q02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 21.40 | 84.90 | 1 | 1454 | 0.0007 | -0.6616 | MN20160318_Q02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 21.40 | 84.90 | 919 | 1454 | 0.6318 | 0.7880 | MN20160318_Q02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 23.10 | 84.90 | 560 | 1616 | 0.3465 | 0.5586 | MN20160318_Q02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 23.10 | 84.90 | 722 | 1616 | 0.4467 | 0.6546 | MN20160318_Q02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 23.10 | 84.90 | 1 | 1616 | 0.0006 | -0.6483 | MN20160318_Q02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 23.10 | 84.90 | 861 | 1616 | 0.5327 | 0.7246 | MN20160318_Q02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 24.81 | 84.90 | 718 | 1769 | 0.4058 | 0.6279 | MN20160318_Q02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 24.81 | 84.90 | 895 | 1769 | 0.5058 | 0.7119 | MN20160318_Q02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 24.81 | 84.90 | 1 | 1769 | 0.0006 | -0.6371 | MN20160318_Q02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 24.81 | 84.90 | 891 | 1769 | 0.5035 | 0.7101 | MN20160318_Q02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 26.51 | 84.90 | 671 | 1923 | 0.3489 | 0.5829 | MN20160318_Q02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 26.51 | 84.90 | 784 | 1923 | 0.4077 | 0.6386 | MN20160318_Q02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 26.51 | 84.90 | 2 | 1923 | 0.0010 | -0.5651 | MN20160318_Q02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 26.51 | 84.90 | 862 | 1923 | 0.4482 | 0.6735 | MN20160318_Q02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 28.21 | 84.90 | 636 | 2091 | 0.3041 | 0.5459 | MN20160318_Q02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 28.21 | 84.90 | 729 | 2091 | 0.3486 | 0.5923 | MN20160318_Q02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 28.21 | 84.90 | 2 | 2091 | 0.0010 | -0.5555 | MN20160318_Q02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 28.21 | 84.90 | 897 | 2091 | 0.4289 | 0.6653 | MN20160318_Q02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 29.92 | 84.90 | 700 | 2237 | 0.3128 | 0.5635 | MN20160318_Q02 | E08 |